Boulder iQ, Boulder Sterilization, Jim Kasic, Ethylene oxide, chlorine dioxide sterilization, life science products, regulatory services, product design, medical device

BIOMEDevice 2024: Innovation in Med Device Development

December 6, 2024

BIOMEDevice claims to be a “one-of-a-kind” expo and education event that “brings together the brightest minds in the industry to demonstrate and discuss emerging trends, innovation, and disruptive tech changing the future of the medical device industry.”

Its claims are true, if my experience is any indicator.

I recently attended the event in Santa Clara, California, and had the opportunity to meet with medical device developers from a wide array of specialties. I found a tremendous appetite for innovation, in device ideation, product development and device usage – all with focus on breakthroughs that can make a difference for patients.

Future of medical devices
Conversations abounded on brain health, cardiovascular device advances and combination therapies – in which medical devices are working to solve problems traditionally solved with pharmaceuticals. Digital health devices, at-home diagnostics, and the role of artificial intelligence in treatment planning and patient monitoring are trends that are no longer “emerging.” They’re here and progressing quickly.

Environmental concerns were top of mind for the developer community. Manufacturers are facing growing pressure to accelerate product development while incorporating eco-friendly practice and materials. Alternatives to ethylene oxide sterilization, such as chlorine dioxide, were big topics, as was the use of sustainable materials in manufacturing.

Supplier needs – and solutions
From a supplier perspective, developers are looking for innovative processes while maintaining the high standards required in the industry. They are facing challenges in navigating the complex regulatory landscape, and need ways to accelerate the process to speed products to market. They need sterilization suppliers with faster turnaround ties, particularly with engineering runs, R&D work, and other small-batch needs.

Boulder Sterilization’s short turnaround times definitely piqued interest. With sterilization cycles generally taking four business days, and validations 8-10 weeks, many developers started to see workable alternatives to their current product development schedules.

Taking action
If your team is tackling similar challenges or exploring eco-friendly innovations, contact me to see how Boulder iQ can help.

Sep Mohseni, Director of Global Sales.  Email Sep.

 

Back to blog home page.